Falciparum Malaria: Clinical Trials

3 trials for Falciparum Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Falciparum Malaria: new trials by email Literature Review of Falciparum Malaria trials Research Report on Falciparum Malaria

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas
primaquine - Malaria, Vivax Malaria
Phase 4CompletedMenzies School of Health Research5002019-08-182023-11-21
Tracking Resistance to Artemisinin (TRAC)
Artesunate 2, Artesunate 4 - Falciparum Malaria
Phase 4CompletedUniversity of Oxford17002011-05-012015-06-01
A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects
Flavoquine®, Camoquin® Suspension - Falciparum Malaria
Phase 4CompletedPfizer382009-05-012010-04-21

Narrower conditions

Malaria, Falciparum (3)  ·  Malaria (1)  ·  Malaria, Vivax (1)

Broader conditions

Infections (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)  ·  Malaria (2)

Interventions

Amodiaquine (1)  ·  Primaquine (1)

Sponsors

Menzies School of Health Research (1)  ·  Pfizer (1)  ·  University of Oxford (1)

Countries

Bangladesh (2)  ·  India (2)  ·  Burma (1)  ·  Cambodia (1)  ·  Democratic Republic of the Congo (1)  ·  Ethiopia (1)  ·  Indonesia (1)  ·  Kenya (1)  ·  Laos (1)  ·  Nigeria (1)  ·  Thailand (1)  ·  Vietnam (1)

Top investigators

Kamala Thriemer, MD (1)  ·  Nicholas J White, DSc MD (1)

Results publications

PMID 25075834, PMID 35585641, PMID 37979594, PMID 42439801